Spectral AI Inc (MDAI) Stock Analysis
Verdict: AVOID
Aggressive insider buying battles a deteriorating balance sheet and -82% margins — a speculative bet on clinical validation over cash flow.
Investment score: 38/100
Analysis as of
Is Spectral AI Inc stock worth reviewing? AI model thesis
MDAI is a high-risk micro-cap with failing fundamentals but strong insider support; the model avoids due to insolvency risk.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 25/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 35/100 (weight 15%)
Spectral AI Inc opportunities and risks
What speaks for MDAI
- Heavy Insider Accumulation
What speaks against MDAI
- Imminent Liquidity Crunch and Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MDAI | n/a | 3.3x | n/a | 44.7% | -85.6% | -22.1% |
| ECOR | n/a | 1.9x | n/a | 87.2% | -44.1% | -10.2% |
| AOTI.L | 120.8x | 2.2x | 22.3x | 52.3% | 1.8% | -8.3% |
| POSC | n/a | 49.4x | n/a | -442.2% | -1996.3% | -18.2% |
| POCI | n/a | 1.4x | n/a | 13.8% | -17.0% | -4.5% |
| DXR | 5.2x | 318.7x | 5.0x | -57.5% | 6105.3% | 0.4% |
| Peer median | n/a | 2.2x | n/a | 13.8% | -17.0% | -8.3% |
Frequently asked questions about Spectral AI Inc (MDAI)
Is MDAI stock a good investment?
The cached TradeMates AI model rates Spectral AI Inc as AVOID with an investment score of 38/100. MDAI is a high-risk micro-cap with failing fundamentals but strong insider support; the model avoids due to insolvency risk. This is algorithmic model output, not personal investment advice.
Is MDAI stock a buy?
The TradeMates model verdict for MDAI is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.